ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Down 70.7% in December
by Kim Johansen · The Markets DailyProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) saw a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 15,700 shares, a decrease of 70.7% from the November 30th total of 53,500 shares. Based on an average trading volume of 279,600 shares, the days-to-cover ratio is presently 0.1 days.
ProtoKinetix Stock Performance
Shares of PKTX stock traded up $0.00 during trading on Friday, reaching $0.01. 21,272 shares of the company’s stock traded hands, compared to its average volume of 121,706. ProtoKinetix has a 1 year low of $0.01 and a 1 year high of $0.02. The firm’s 50-day moving average is $0.01 and its 200 day moving average is $0.01.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.
Further Reading
- Five stocks we like better than ProtoKinetix
- 3 Small Caps With Big Return Potential
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- What Is WallStreetBets and What Stocks Are They Targeting?
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Consumer Discretionary Stocks Explained
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?